Produkt mají v nabídce:
Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics
Currently, hemoglobin (Hb)-based oxygen carriers (HBOCs) are leading candidates as red blood cell substitutes. In addition, HBOCs are also potential oxygen therapeutics for treatment of patients with critical ischemic conditions due to atherosclerosis, diabetes and other conditions.
